M Beaton

439 total citations
7 papers, 274 citations indexed

About

M Beaton is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, M Beaton has authored 7 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in M Beaton's work include Inflammatory Bowel Disease (3 papers), Liver Disease and Transplantation (2 papers) and Pancreatitis Pathology and Treatment (2 papers). M Beaton is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Liver Disease and Transplantation (2 papers) and Pancreatitis Pathology and Treatment (2 papers). M Beaton collaborates with scholars based in Canada, Romania and United Kingdom. M Beaton's co-authors include Mark Levstik, Paul C. Adams, Nilesh Chande, Erin Boyce, Marko Mrkobrada, Subrata Chakrabarti, Mark Speechley, Paul Marotta, Catherine T. Schentag and Proton Rahman and has published in prestigious journals such as Journal of Hepatology, Alimentary Pharmacology & Therapeutics and Journal of Crohn s and Colitis.

In The Last Decade

M Beaton

6 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Beaton Canada 4 161 137 125 33 30 7 274
Violaine Ozenne France 7 100 0.6× 160 1.2× 101 0.8× 24 0.7× 35 1.2× 13 242
S. Haque United States 7 86 0.5× 118 0.9× 188 1.5× 44 1.3× 41 1.4× 8 364
F. Barbaria Italy 9 244 1.5× 162 1.2× 52 0.4× 42 1.3× 62 2.1× 11 327
Gerasimos Baltayiannis Greece 11 196 1.2× 207 1.5× 72 0.6× 13 0.4× 7 0.2× 23 331
Marjan Rahsaz Iran 12 126 0.8× 71 0.5× 97 0.8× 16 0.5× 15 0.5× 29 350
Giorgina Mieli-Vergani United Kingdom 11 304 1.9× 368 2.7× 154 1.2× 24 0.7× 23 0.8× 14 549
Giovanni Antonio Touscoz Italy 11 218 1.4× 206 1.5× 84 0.7× 5 0.2× 20 0.7× 16 333
Ouki Yasui Japan 11 54 0.3× 87 0.6× 171 1.4× 22 0.7× 29 1.0× 30 363
Hiroko Suda Japan 12 53 0.3× 69 0.5× 190 1.5× 14 0.4× 57 1.9× 26 360
Benjamin Rivière France 9 112 0.7× 119 0.9× 104 0.8× 5 0.2× 6 0.2× 24 305

Countries citing papers authored by M Beaton

Since Specialization
Citations

This map shows the geographic impact of M Beaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Beaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Beaton more than expected).

Fields of papers citing papers by M Beaton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Beaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Beaton. The network helps show where M Beaton may publish in the future.

Co-authorship network of co-authors of M Beaton

This figure shows the co-authorship network connecting the top 25 collaborators of M Beaton. A scholar is included among the top collaborators of M Beaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Beaton. M Beaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Vuyyuru, Sudheer K., Virginia Solitano, Leonardo Guizzetti, et al.. (2024). P550 Short and long-term outcomes after acute severe ulcerative colitis in adults: A 12 year Canadian experience in the post biologic era. Journal of Crohn s and Colitis. 18(Supplement_1). i1075–i1076.
2.
D’Haens, Geert, M Beaton, Peter Bossuyt, et al.. (2022). P544 Patients with moderate to severe Crohn’s disease with and without prior biologic failure demonstrated improved clinical outcomes with risankizumab: Results from phase 3 induction and maintenance trials. Journal of Crohn s and Colitis. 16(Supplement_1). i491–i491. 1 indexed citations
3.
Wilson, Aze, James C. Gregor, Terry Ponich, et al.. (2017). HLADQA1‐HLADRB1 polymorphism is a major predictor of azathioprine‐induced pancreatitis in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 47(5). 615–620. 50 indexed citations
4.
Beaton, M, Subrata Chakrabarti, Mark Levstik, et al.. (2013). Phase II clinical trial of phlebotomy for non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 37(7). 720–729. 62 indexed citations
5.
Chande, Nilesh, Paul C. Adams, M Beaton, et al.. (2012). Meta‐analysis: vasoactive medications for the management of acute variceal bleeds. Alimentary Pharmacology & Therapeutics. 35(11). 1267–1278. 140 indexed citations
6.
Myers, Robert P., Gilles Pomier–Layrargues, Andrés Duarte‐Rojo, et al.. (2011). 341 PERFORMANCE OF THE FIBROSCAN XL PROBE FOR LIVER STIFFNESS MEASUREMENT IN OBESE PATIENTS: A MULTICENTER VALIDATION STUDY. Journal of Hepatology. 54. S136–S137. 3 indexed citations
7.
Rahman, Proton, Catherine T. Schentag, M Beaton, & Dafna D. Gladman. (2000). Comparison of clinical and immunogenetic features in familial versus sporadic psoriatic arthritis.. PubMed. 18(1). 7–12. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026